Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten ...

A hot jobs report makes it even more likely the Federal Reserve won’t cut rates at its next meeting in January — or for the foreseeable future.

We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...

Blake Gwinn, the head of US Rates Strategy at RBC Capital Markets, joins Yahoo Finance's Morning Brief to explain why the ...

Speaking to analysts on the television and radio broadcaster's first-quarter earnings call Friday, co-CEO Troy Reeb called ...

RBC has partnered with Cohere, a company specializing in security and privacy-focused enterprise AI, to co-develop North for ...

RBC Capital Markets raised its recommendation on KB Home (NYSE:KBH) and Lennar (NYSE:LEN), considering the homebuilders' ...

Investing.com -- Shares of Apellis Pharmaceuticals (NASDAQ: APLS) fell 8.9% in premarket trading following news that the FDA accepted a revised supplemental application from competitor Astellas Pharma ...

RBC Capital lowered the firm’s price target on Equity Lifestyle (ELS) to $69 from $72 and keeps a Sector Perform rating on ...

Daily roundup of research and analysis from The Globe and Mail’s market strategist Scott Barlow ...

The yield on 10-year UK gilts rose by three basis points to 4.82%, having this week hit their highest level since 2008.